Alaethes Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.15M | Buy |
31,207
+3,673
| +13% | +$254K | 0.64% | 52 |
|
|
2025
Q1 | $1.94M | Buy |
27,534
+2,612
| +10% | +$184K | 0.71% | 50 |
|
|
2024
Q4 | $2.14M | Buy |
24,922
+256
| +1% | +$22K | 0.77% | 42 |
|
|
2024
Q3 | $2.94M | Buy |
24,666
+373
| +2% | +$44.4K | 1.08% | 18 |
|
|
2024
Q2 | $3.47M | Buy |
24,293
+336
| +1% | +$48K | 1.43% | 13 |
|
|
2024
Q1 | $3.1M | Buy |
23,957
+1,524
| +7% | +$197K | 1.35% | 14 |
|
|
2023
Q4 | $2.32M | Buy |
22,433
+460
| +2% | +$47.6K | 1.1% | 23 |
|
|
2023
Q3 | $2M | Buy |
21,973
+1,789
| +9% | +$163K | 1.09% | 22 |
|
|
2023
Q2 | $1.63M | Sell |
20,184
-840
| -4% | -$68K | 0.9% | 36 |
|
|
2023
Q1 | $1.67M | Buy |
21,024
+776
| +4% | +$61.7K | 0.98% | 26 |
|
|
2022
Q4 | $1.37M | Buy |
20,248
+208
| +1% | +$14.1K | 0.94% | 41 |
|
|
2022
Q3 | $998K | Buy |
20,040
+996
| +5% | +$49.6K | 0.73% | 57 |
|
|
2022
Q2 | $1.06M | Buy |
19,044
+928
| +5% | +$51.7K | 0.79% | 50 |
|
|
2022
Q1 | $1.01M | Buy |
18,116
+2,742
| +18% | +$152K | 0.64% | 64 |
|
|
2021
Q4 | $861K | Buy |
+15,374
| New | +$861K | 0.54% | 73 |
|